The origins of cyanobactin chemistry and biology

Marcel Jaspars*

*Corresponding author for this work

Research output: Contribution to journalEditorial

8 Citations (Scopus)

Abstract

The correct structure of the symmetrical cyanobactin, ascidiacyclamide, was published in Chemical Communications by Hamamoto et al. in 1983. The cyanobactin family of compounds are cyclic peptides with modifications including azole/azoline rings, D-stereocentres and in some cases prenyl groups. Although related compounds were isolated earlier by Ireland et al., two of the three published structures later had to be corrected. Hamamoto's ascidiacyclamide structure assisted the understanding of the chemistry, bioactivity, biological origin and biosynthesis of this group of compounds. Cyanobactins are of interest as new chemotypes for the treatment of a range of diseases, in particular those in which extended binding sites are implicated.

Original languageEnglish
Pages (from-to)10174-10176
Number of pages3
JournalChemical Communications
Volume50
Issue number71
Early online date23 Jul 2014
DOIs
Publication statusPublished - 14 Sep 2014

Keywords

  • tunicate lissoclinum-patella
  • cyclic-peptides
  • marine tunicate
  • macrocyclization
  • ascidiacyclamide
  • diversity
  • discovery
  • symbiont
  • pathway
  • route

Cite this

The origins of cyanobactin chemistry and biology. / Jaspars, Marcel.

In: Chemical Communications, Vol. 50, No. 71, 14.09.2014, p. 10174-10176.

Research output: Contribution to journalEditorial

@article{25c36da3c038459097128484a9d542da,
title = "The origins of cyanobactin chemistry and biology",
abstract = "The correct structure of the symmetrical cyanobactin, ascidiacyclamide, was published in Chemical Communications by Hamamoto et al. in 1983. The cyanobactin family of compounds are cyclic peptides with modifications including azole/azoline rings, D-stereocentres and in some cases prenyl groups. Although related compounds were isolated earlier by Ireland et al., two of the three published structures later had to be corrected. Hamamoto's ascidiacyclamide structure assisted the understanding of the chemistry, bioactivity, biological origin and biosynthesis of this group of compounds. Cyanobactins are of interest as new chemotypes for the treatment of a range of diseases, in particular those in which extended binding sites are implicated.",
keywords = "tunicate lissoclinum-patella, cyclic-peptides, marine tunicate, macrocyclization, ascidiacyclamide, diversity, discovery, symbiont, pathway, route",
author = "Marcel Jaspars",
note = "Accepted 23 Jul 2014",
year = "2014",
month = "9",
day = "14",
doi = "10.1039/c3cc49252d",
language = "English",
volume = "50",
pages = "10174--10176",
journal = "Chemical Communications",
issn = "1359-7345",
publisher = "Royal Society of Chemistry",
number = "71",

}

TY - JOUR

T1 - The origins of cyanobactin chemistry and biology

AU - Jaspars, Marcel

N1 - Accepted 23 Jul 2014

PY - 2014/9/14

Y1 - 2014/9/14

N2 - The correct structure of the symmetrical cyanobactin, ascidiacyclamide, was published in Chemical Communications by Hamamoto et al. in 1983. The cyanobactin family of compounds are cyclic peptides with modifications including azole/azoline rings, D-stereocentres and in some cases prenyl groups. Although related compounds were isolated earlier by Ireland et al., two of the three published structures later had to be corrected. Hamamoto's ascidiacyclamide structure assisted the understanding of the chemistry, bioactivity, biological origin and biosynthesis of this group of compounds. Cyanobactins are of interest as new chemotypes for the treatment of a range of diseases, in particular those in which extended binding sites are implicated.

AB - The correct structure of the symmetrical cyanobactin, ascidiacyclamide, was published in Chemical Communications by Hamamoto et al. in 1983. The cyanobactin family of compounds are cyclic peptides with modifications including azole/azoline rings, D-stereocentres and in some cases prenyl groups. Although related compounds were isolated earlier by Ireland et al., two of the three published structures later had to be corrected. Hamamoto's ascidiacyclamide structure assisted the understanding of the chemistry, bioactivity, biological origin and biosynthesis of this group of compounds. Cyanobactins are of interest as new chemotypes for the treatment of a range of diseases, in particular those in which extended binding sites are implicated.

KW - tunicate lissoclinum-patella

KW - cyclic-peptides

KW - marine tunicate

KW - macrocyclization

KW - ascidiacyclamide

KW - diversity

KW - discovery

KW - symbiont

KW - pathway

KW - route

U2 - 10.1039/c3cc49252d

DO - 10.1039/c3cc49252d

M3 - Editorial

VL - 50

SP - 10174

EP - 10176

JO - Chemical Communications

JF - Chemical Communications

SN - 1359-7345

IS - 71

ER -